115 related articles for article (PubMed ID: 30481877)
1. [Genes and molecular mechanisms affecting the correlation between liver cancer and diabetes mellitus].
Yang Y; Zhang BH; Gong JP
Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):718-720. PubMed ID: 30481877
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
3. A single non-synonymous NCOA5 variation in type 2 diabetic patients with hepatocellular carcinoma impairs the function of NCOA5 in cell cycle regulation.
Liu X; Liu F; Gao S; Reske J; Li A; Wu CL; Yang C; Chen F; Luo R; Xiao H
Cancer Lett; 2017 Apr; 391():152-161. PubMed ID: 28137631
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management.
Singh MK; Das BK; Choudhary S; Gupta D; Patil UK
Biomed Pharmacother; 2018 Oct; 106():991-1002. PubMed ID: 30119271
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
6. Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma.
Chettouh H; Lequoy M; Fartoux L; Vigouroux C; Desbois-Mouthon C
Liver Int; 2015 Oct; 35(10):2203-17. PubMed ID: 26123841
[TBL] [Abstract][Full Text] [Related]
7. Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma.
Makol A; Kanthaje S; Dhiman RK; Kalra N; Chawla YK; Chakraborti A
Exp Biol Med (Maywood); 2018 Feb; 243(4):323-326. PubMed ID: 29186978
[TBL] [Abstract][Full Text] [Related]
8. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus and metformin in hepatocellular carcinoma.
Fujita K; Iwama H; Miyoshi H; Tani J; Oura K; Tadokoro T; Sakamoto T; Nomura T; Morishita A; Yoneyama H; Masaki T
World J Gastroenterol; 2016 Jul; 22(27):6100-13. PubMed ID: 27468203
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in Japan.
Akuta N; Kawamura Y; Arase Y; Saitoh S; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Kobayashi M; Suzuki Y; Suzuki F; Ikeda K; Kumada H
BMC Gastroenterol; 2018 Nov; 18(1):165. PubMed ID: 30400829
[TBL] [Abstract][Full Text] [Related]
12. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment.
Agosti P; Sabbà C; Mazzocca A
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):607-617. PubMed ID: 29197664
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus increases the risk of intrahepatic recurrence of hepatocellular carcinoma after surgical resection.
Choi Y; Choi Y; Choi CS; Lee YH
Tumori; 2017 May; 103(3):279-285. PubMed ID: 28085178
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus in patients with cirrhosis: clinical implications and management.
Elkrief L; Rautou PE; Sarin S; Valla D; Paradis V; Moreau R
Liver Int; 2016 Jul; 36(7):936-48. PubMed ID: 26972930
[TBL] [Abstract][Full Text] [Related]
15. Aerobic exercise regulates blood lipid and insulin resistance via the toll‑like receptor 4‑mediated extracellular signal‑regulated kinases/AMP‑activated protein kinases signaling pathway.
Wang M; Li S; Wang F; Zou J; Zhang Y
Mol Med Rep; 2018 Jun; 17(6):8339-8348. PubMed ID: 29658605
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma?
Gao C; Yao SK
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):465-73. PubMed ID: 19822488
[TBL] [Abstract][Full Text] [Related]
17. Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis.
Wainwright P; Scorletti E; Byrne CD
Curr Diab Rep; 2017 Apr; 17(4):20. PubMed ID: 28290049
[TBL] [Abstract][Full Text] [Related]
18. Diabetes, insulin, and risk of cancer.
Schiel R; Beltschikow W; Steiner T; Stein G
Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):169-75. PubMed ID: 16810343
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.
Hassan MM; Hwang LY; Hatten CJ; Swaim M; Li D; Abbruzzese JL; Beasley P; Patt YZ
Hepatology; 2002 Nov; 36(5):1206-13. PubMed ID: 12395331
[TBL] [Abstract][Full Text] [Related]
20. NAFLD and diabetes mellitus.
Tilg H; Moschen AR; Roden M
Nat Rev Gastroenterol Hepatol; 2017 Jan; 14(1):32-42. PubMed ID: 27729660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
